Fibrin Formation Steps
The conversion of soluble fibrinogen into an insoluble fibrin gel occurs through several sequential steps:
- Monomer formation: Thrombin cleaves negatively charged fibrinopeptides A and B from fibrinogen. The loss of negative charge eliminates electrostatic repulsion between molecules, resulting in fibrin monomers.
- Polymerization (aggregation): Complementary binding sites are exposed on the monomers. In the presence of $Ca^{2+}$, weak non-covalent bonds form between them, self-assembling into a fibrin polymer (soluble fibrin). At this stage, the clot remains unstable.
- Stabilization (insoluble fibrin formation): Enzymatic cross-linking is required to turn the gel into a stable thrombus. Transglutaminase (Factor XIIIa, activated by thrombin) creates strong covalent amide bonds between glutamine and lysine residues of adjacent monomers, as well as between fibrin and fibronectin. Tissue fibrinases also contribute to stabilization.
- Retraction: The final compression and consolidation of the clot, squeezing out serum. This occurs via platelet contractile proteins (thrombosthenin) and requires ATP.
Fibrin Degradation (Fibrinolysis)
The process of dissolving a fibrin clot is called fibrinolysis. It is essential for clearing the vascular lumen of fibrin deposits and preventing vessel occlusion.
- The primary active enzyme is plasmin.
- Under the action of plasmin, peptide bonds within fibrin are cleaved.
- This results in the formation of fibrin degradation products (peptides and amino acids).
Clinical Significance and Pathology
In addition to physiological hemostasis, fibrin and fibrinoid material play a role in several pathological and physiological processes:
- Hyaline membranes: In infant respiratory distress syndrome (IRDS), fibrin forms the structural core of membranes deposited directly on the basement membrane at sites of epithelial necrosis. These membranes also contain tyrosine, $\alpha_1$-antitrypsin, and the $C_3$ complement component.
- Rheumatic diseases: Fibrin is an essential component of fibrinoid, a complex mixture comprising degraded collagen fiber proteins and polysaccharides, ground substance components, blood plasma, and cellular nucleoproteins. Fibrin forms from fibrinogen via tissue thrombokinase (tissue factor).
- Amniotic fluid embolism (AFE): AFE leads to platelet-fibrin microthrombi that obstruct pulmonary capillaries and increase pulmonary vascular resistance. AFE is accompanied by disseminated intravascular coagulation (DIC) and coagulopathy; clinical presentation may feature hypofibrinogenemia and consumption of clotting factors, leading to massive hemorrhage.
- Inflammatory conditions: Fibrin exudates are found on the surface of abscesses (e.g., ovarian abscess) and within alveolar exudate in chlamydial pneumonia.
Role of Fibrinoid in Pregnancy
Fibrinoid is an acellular fibrin-like material composed of blood components and tissue degradation products.
- Normal physiological state: During normal pregnancy, the smooth muscle and elastic layers of maternal spiral arteries are degraded and replaced by a prominent layer of fibrinoid. Langhans fibrinoid is localized on the surface of chorionic villi, while Rohr fibrinoid is located on the septal surface bordering the intervillous space.
- Pathological state (preeclampsia): Acute atherosis develops—excessive fibrinoid accumulation in arterial walls alongside lipid-laden foam cells. Spiral artery pathology leads to impaired placental perfusion.